| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 3-kinase activity | 2.37e-04 | 7 | 68 | 2 | GO:0035005 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity | 2.37e-04 | 7 | 68 | 2 | GO:0046934 | |
| GeneOntologyMolecularFunction | complement component C1q complex binding | 5.05e-04 | 10 | 68 | 2 | GO:0001849 | |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 5.16e-04 | 46 | 68 | 3 | GO:0004715 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 6.16e-04 | 11 | 68 | 2 | GO:0016303 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 7.51e-04 | 120 | 68 | 4 | GO:0008013 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 9.49e-04 | 599 | 68 | 8 | GO:0050839 | |
| GeneOntologyMolecularFunction | insulin receptor substrate binding | 1.17e-03 | 15 | 68 | 2 | GO:0043560 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 1.22e-03 | 938 | 68 | 10 | GO:0016772 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.52e-03 | 145 | 68 | 4 | GO:0004713 | |
| GeneOntologyBiologicalProcess | innate immune response | DHX15 JAK2 FCGR2B PIK3CD HPX C4A TRIM34 C4B IL17RA TRIM22 MEFV PTK6 TXK NLRP6 | 7.31e-06 | 1092 | 66 | 14 | GO:0045087 |
| GeneOntologyBiologicalProcess | positive regulation of immune response | JAK2 FCGR2B PIK3CA PIK3CD HPX HLA-H C4A C4B BAG6 MEFV TXK NLRP6 | 1.33e-05 | 845 | 66 | 12 | GO:0050778 |
| GeneOntologyBiologicalProcess | defense response to other organism | DHX15 JAK2 FCGR2B PIK3CD HPX HLA-H C4A TRIM34 C4B IL17RA TRIM22 MEFV PTK6 TXK NLRP6 | 2.93e-05 | 1407 | 66 | 15 | GO:0098542 |
| GeneOntologyBiologicalProcess | defense response to symbiont | DHX15 JAK2 FCGR2B PIK3CD HPX C4A TRIM34 C4B IL17RA TRIM22 MEFV PTK6 TXK NLRP6 | 4.54e-05 | 1286 | 66 | 14 | GO:0140546 |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 4.64e-05 | 62 | 66 | 4 | GO:0002455 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-mediated signaling | 6.04e-05 | 24 | 66 | 3 | GO:0048015 | |
| GeneOntologyBiologicalProcess | type II interferon-mediated signaling pathway | 8.66e-05 | 27 | 66 | 3 | GO:0060333 | |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.10e-04 | 462 | 66 | 8 | GO:0002460 | |
| GeneOntologyBiologicalProcess | regulation of immune response | JAK2 FCGR2B PIK3CA PIK3CD HPX HLA-H C4A C4B BAG6 MEFV TXK NLRP6 | 1.49e-04 | 1085 | 66 | 12 | GO:0050776 |
| GeneOntologyBiologicalProcess | trunk neural crest cell migration | 1.50e-04 | 6 | 66 | 2 | GO:0036484 | |
| GeneOntologyBiologicalProcess | trunk segmentation | 1.50e-04 | 6 | 66 | 2 | GO:0035290 | |
| GeneOntologyBiologicalProcess | positive regulation of response to type II interferon | 1.50e-04 | 6 | 66 | 2 | GO:0060332 | |
| GeneOntologyBiologicalProcess | positive regulation of type II interferon-mediated signaling pathway | 1.50e-04 | 6 | 66 | 2 | GO:0060335 | |
| GeneOntologyBiologicalProcess | activation of immune response | 1.57e-04 | 623 | 66 | 9 | GO:0002253 | |
| GeneOntologyBiologicalProcess | blastoderm segmentation | 1.90e-04 | 35 | 66 | 3 | GO:0007350 | |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic cell clearance | 2.79e-04 | 8 | 66 | 2 | GO:2000427 | |
| GeneOntologyBiologicalProcess | adaptive immune response | 3.11e-04 | 838 | 66 | 10 | GO:0002250 | |
| GeneOntologyCellularComponent | symbiont cell surface | 2.88e-04 | 8 | 68 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class I | 3.70e-04 | 9 | 68 | 2 | GO:0097651 | |
| GeneOntologyCellularComponent | other organism part | 3.70e-04 | 9 | 68 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class IA | 3.70e-04 | 9 | 68 | 2 | GO:0005943 | |
| GeneOntologyCellularComponent | microfibril | 7.95e-04 | 13 | 68 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 9.16e-04 | 230 | 68 | 5 | GO:0019898 | |
| HumanPheno | Abnormal arterial physiology | 8.52e-06 | 181 | 31 | 8 | HP:0025323 | |
| HumanPheno | Polyarticular arthritis | 1.04e-05 | 50 | 31 | 5 | HP:0005764 | |
| HumanPheno | Polyarticular arthropathy | 1.27e-05 | 52 | 31 | 5 | HP:0005195 | |
| HumanPheno | Abnormality of skin physiology | JAK2 TGM1 FCGR2B RNASEH2A PIK3CA PIK3CD CDH23 C4A C4B IL17RA SIK3 AR MEFV | 1.78e-05 | 593 | 31 | 13 | HP:0011122 |
| HumanPheno | Inflammatory abnormality of the skin | TGM1 FCGR2B RNASEH2A PIK3CA PIK3CD CDH23 C4A C4B IL17RA SIK3 AR MEFV | 2.63e-05 | 521 | 31 | 12 | HP:0011123 |
| HumanPheno | Gastrointestinal hemorrhage | 4.32e-05 | 164 | 31 | 7 | HP:0002239 | |
| HumanPheno | Anorexia | 8.24e-05 | 124 | 31 | 6 | HP:0002039 | |
| HumanPheno | Arthropathy | 9.20e-05 | 78 | 31 | 5 | HP:0003040 | |
| HumanPheno | Pulmonary embolism | 1.17e-04 | 43 | 31 | 4 | HP:0002204 | |
| HumanPheno | Abnormal pigmentation of the oral mucosa | 1.29e-04 | 44 | 31 | 4 | HP:0100669 | |
| HumanPheno | Abnormal vascular physiology | 1.53e-04 | 348 | 31 | 9 | HP:0030163 | |
| HumanPheno | Headache | 1.67e-04 | 352 | 31 | 9 | HP:0002315 | |
| HumanPheno | Increased inflammatory response | JAK2 TGM1 FCGR2B RNASEH2A PIK3CA PIK3CD AMACR CDH23 C4A C4B IL17RA SIK3 LTBP4 DDB1 AR PHIP PALB2 MEFV | 2.07e-04 | 1355 | 31 | 18 | HP:0012649 |
| HumanPheno | Abnormal inflammatory response | JAK2 TGM1 FCGR2B RNASEH2A PIK3CA PIK3CD AMACR CDH23 C4A C4B IL17RA SIK3 LTBP4 DDB1 AR PHIP PALB2 MEFV | 2.07e-04 | 1355 | 31 | 18 | HP:0012647 |
| HumanPheno | Migraine | 2.73e-04 | 154 | 31 | 6 | HP:0002076 | |
| HumanPheno | Pedal edema | 2.87e-04 | 54 | 31 | 4 | HP:0010741 | |
| HumanPheno | Raynaud phenomenon | 3.08e-04 | 55 | 31 | 4 | HP:0030880 | |
| HumanPheno | Memory impairment | 3.13e-04 | 158 | 31 | 6 | HP:0002354 | |
| HumanPheno | Chronic leukemia | 3.33e-04 | 23 | 31 | 3 | HP:0005558 | |
| HumanPheno | Serositis | 3.43e-04 | 103 | 31 | 5 | HP:0045073 | |
| HumanPheno | Abnormal cerebral vascular morphology | 3.50e-04 | 388 | 31 | 9 | HP:0100659 | |
| HumanPheno | Weight loss | 3.50e-04 | 388 | 31 | 9 | HP:0001824 | |
| HumanPheno | Cheilitis | 3.79e-04 | 58 | 31 | 4 | HP:0100825 | |
| HumanPheno | Vascular skin abnormality | THSD4 JAK2 TGM1 VWF RNASEH2A PIK3CA CDH23 C4A IL17RA SIK3 MEFV | 4.59e-04 | 593 | 31 | 11 | HP:0011276 |
| HumanPheno | Abnormal cerebral artery morphology | 4.80e-04 | 171 | 31 | 6 | HP:0009145 | |
| HumanPheno | Abnormality of blood circulation | 4.86e-04 | 498 | 31 | 10 | HP:0011028 | |
| HumanPheno | Fatigue | 5.02e-04 | 500 | 31 | 10 | HP:0012378 | |
| HumanPheno | Lymphadenopathy | 5.73e-04 | 248 | 31 | 7 | HP:0002716 | |
| HumanPheno | Pleuritis | 6.03e-04 | 28 | 31 | 3 | HP:0002102 | |
| HumanPheno | Arthritis | 6.16e-04 | 251 | 31 | 7 | HP:0001369 | |
| HumanPheno | Breast carcinoma | 6.58e-04 | 67 | 31 | 4 | HP:0003002 | |
| HumanPheno | Abnormal size of pituitary gland | 6.70e-04 | 29 | 31 | 3 | HP:0012504 | |
| HumanPheno | Internal hemorrhage | 7.20e-04 | 339 | 31 | 8 | HP:0011029 | |
| HumanPheno | Abnormal lymphocyte morphology | 7.30e-04 | 524 | 31 | 10 | HP:0004332 | |
| HumanPheno | Anti-complement component C1q antibody positivity | 7.41e-04 | 30 | 31 | 3 | HP:0034077 | |
| HumanPheno | Anti-ribosome Po antibody positivity | 7.41e-04 | 30 | 31 | 3 | HP:0034076 | |
| HumanPheno | Anti-phosphatidic acid antibody positivity | 7.41e-04 | 30 | 31 | 3 | HP:0034096 | |
| HumanPheno | Anti-Ro52/TRIM21 antibody positivity | 7.41e-04 | 30 | 31 | 3 | HP:0034093 | |
| HumanPheno | Anti-La/SS-B antibody positivity | 7.41e-04 | 30 | 31 | 3 | HP:0032235 | |
| HumanPheno | Anti-nucleoporin 62 antibody positivity | 7.41e-04 | 30 | 31 | 3 | HP:0033556 | |
| HumanPheno | Anti-titin antibody positivity | 7.41e-04 | 30 | 31 | 3 | HP:5000038 | |
| HumanPheno | Abnormal epididymis morphology | 7.41e-04 | 30 | 31 | 3 | HP:0009714 | |
| HumanPheno | Cerebral ischemia | 7.77e-04 | 123 | 31 | 5 | HP:0002637 | |
| HumanPheno | Tissue ischemia | 7.77e-04 | 123 | 31 | 5 | HP:0033401 | |
| HumanPheno | Abnormal lymph node morphology | 8.15e-04 | 263 | 31 | 7 | HP:0002733 | |
| HumanPheno | Pyuria | 8.18e-04 | 31 | 31 | 3 | HP:0012085 | |
| HumanPheno | Acne | 8.21e-04 | 71 | 31 | 4 | HP:0001061 | |
| HumanPheno | Oral ulcer | 8.21e-04 | 71 | 31 | 4 | HP:0000155 | |
| HumanPheno | Abnormal bleeding | 8.87e-04 | 537 | 31 | 10 | HP:0001892 | |
| HumanPheno | Lupus nephritis | 8.98e-04 | 32 | 31 | 3 | HP:0033726 | |
| HumanPheno | Anti-U1 ribonucleoprotein antibody positivity | 8.98e-04 | 32 | 31 | 3 | HP:0033028 | |
| HumanPheno | Anti-Sm antibody positivity | 8.98e-04 | 32 | 31 | 3 | HP:0033040 | |
| HumanPheno | Tumours of the breast | 9.12e-04 | 73 | 31 | 4 | HP:0010623 | |
| HumanPheno | Pancreatic adenocarcinoma | 9.84e-04 | 33 | 31 | 3 | HP:0006725 | |
| HumanPheno | Depression | 1.01e-03 | 448 | 31 | 9 | HP:0000716 | |
| HumanPheno | Arterial thrombosis | 1.07e-03 | 34 | 31 | 3 | HP:0004420 | |
| HumanPheno | Extractable nuclear antigen positivity | 1.07e-03 | 34 | 31 | 3 | HP:0033476 | |
| HumanPheno | Anti-dsDNA antibody positivity | 1.07e-03 | 34 | 31 | 3 | HP:0020151 | |
| HumanPheno | Decreased circulating complement C4 concentration | 1.17e-03 | 35 | 31 | 3 | HP:0045042 | |
| HumanPheno | Abnormal cellular immune system morphology | JAK2 FCGR2B RNASEH2A PIK3CA PIK3CD CDH23 C4A C4B IL17RA SIK3 PALB2 MEFV | 1.20e-03 | 774 | 31 | 12 | HP:0010987 |
| HumanPheno | Abnormal leukocyte morphology | JAK2 FCGR2B RNASEH2A PIK3CA PIK3CD CDH23 C4A C4B IL17RA SIK3 PALB2 MEFV | 1.20e-03 | 774 | 31 | 12 | HP:0001881 |
| Domain | C345C | 3.16e-05 | 17 | 69 | 3 | SM00643 | |
| Domain | PI3K_p85B | 4.03e-05 | 3 | 69 | 2 | PF02192 | |
| Domain | PI3K_p85B | 4.03e-05 | 3 | 69 | 2 | SM00143 | |
| Domain | NTR | 4.48e-05 | 19 | 69 | 3 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 4.48e-05 | 19 | 69 | 3 | IPR018933 | |
| Domain | PI3K_ABD | 8.03e-05 | 4 | 69 | 2 | PS51544 | |
| Domain | PI3K_adapt-bd_dom | 8.03e-05 | 4 | 69 | 2 | IPR003113 | |
| Domain | NTR | 8.11e-05 | 23 | 69 | 3 | PS50189 | |
| Domain | Netrin_domain | 8.11e-05 | 23 | 69 | 3 | IPR001134 | |
| Domain | TIMP-like_OB-fold | 1.18e-04 | 26 | 69 | 3 | IPR008993 | |
| Domain | Anaphylatoxin_comp_syst | 1.34e-04 | 5 | 69 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.34e-04 | 5 | 69 | 2 | IPR001840 | |
| Domain | SAPAP | 1.34e-04 | 5 | 69 | 2 | IPR005026 | |
| Domain | GKAP | 1.34e-04 | 5 | 69 | 2 | PF03359 | |
| Domain | ConA-like_dom | 1.57e-04 | 219 | 69 | 6 | IPR013320 | |
| Domain | - | 2.18e-04 | 148 | 69 | 5 | 2.60.40.150 | |
| Domain | ANATO | 2.79e-04 | 7 | 69 | 2 | SM00104 | |
| Domain | PI3K_Ras-bd_dom | 2.79e-04 | 7 | 69 | 2 | IPR000341 | |
| Domain | ANATO | 2.79e-04 | 7 | 69 | 2 | PF01821 | |
| Domain | PI3K_rbd | 2.79e-04 | 7 | 69 | 2 | PF00794 | |
| Domain | ANAPHYLATOXIN_2 | 2.79e-04 | 7 | 69 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 2.79e-04 | 7 | 69 | 2 | PS01177 | |
| Domain | PI3K_RBD | 2.79e-04 | 7 | 69 | 2 | PS51546 | |
| Domain | PI3K_rbd | 2.79e-04 | 7 | 69 | 2 | SM00144 | |
| Domain | Anaphylatoxin/fibulin | 2.79e-04 | 7 | 69 | 2 | IPR000020 | |
| Domain | SPRY | 3.01e-04 | 87 | 69 | 4 | SM00449 | |
| Domain | C2_dom | 3.51e-04 | 164 | 69 | 5 | IPR000008 | |
| Domain | PI3K_C2_dom | 3.71e-04 | 8 | 69 | 2 | IPR002420 | |
| Domain | PI3K_C2 | 3.71e-04 | 8 | 69 | 2 | PF00792 | |
| Domain | Thiol-ester_cl | 3.71e-04 | 8 | 69 | 2 | PF10569 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 3.71e-04 | 8 | 69 | 2 | IPR019565 | |
| Domain | PI3K_C2 | 3.71e-04 | 8 | 69 | 2 | PS51547 | |
| Domain | MacrogloblnA2_CS | 3.71e-04 | 8 | 69 | 2 | IPR019742 | |
| Domain | PI3K_C2 | 3.71e-04 | 8 | 69 | 2 | SM00142 | |
| Domain | SPRY | 4.05e-04 | 94 | 69 | 4 | PF00622 | |
| Domain | SPRY_dom | 4.05e-04 | 94 | 69 | 4 | IPR003877 | |
| Domain | B30.2/SPRY | 4.22e-04 | 95 | 69 | 4 | IPR001870 | |
| Domain | B302_SPRY | 4.22e-04 | 95 | 69 | 4 | PS50188 | |
| Domain | PI3Ka | 4.76e-04 | 9 | 69 | 2 | PF00613 | |
| Domain | - | 4.76e-04 | 9 | 69 | 2 | 1.25.40.70 | |
| Domain | PI3Ka | 4.76e-04 | 9 | 69 | 2 | SM00145 | |
| Domain | A2M_N | 5.94e-04 | 10 | 69 | 2 | PF01835 | |
| Domain | A2M_N | 5.94e-04 | 10 | 69 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 5.94e-04 | 10 | 69 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 5.94e-04 | 10 | 69 | 2 | PS00477 | |
| Domain | A2M | 5.94e-04 | 10 | 69 | 2 | PF00207 | |
| Domain | A2M_N_2 | 5.94e-04 | 10 | 69 | 2 | IPR011625 | |
| Domain | A2M_comp | 5.94e-04 | 10 | 69 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 5.94e-04 | 10 | 69 | 2 | PF07703 | |
| Domain | PIK_HELICAL | 5.94e-04 | 10 | 69 | 2 | PS51545 | |
| Domain | A2M_recep | 5.94e-04 | 10 | 69 | 2 | PF07677 | |
| Domain | A2M_comp | 5.94e-04 | 10 | 69 | 2 | PF07678 | |
| Domain | PI_Kinase | 5.94e-04 | 10 | 69 | 2 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 5.94e-04 | 10 | 69 | 2 | IPR001263 | |
| Domain | Macroglobln_a2 | 5.94e-04 | 10 | 69 | 2 | IPR001599 | |
| Domain | PI3/4_kinase_CS | 1.37e-03 | 15 | 69 | 2 | IPR018936 | |
| Domain | - | 1.56e-03 | 16 | 69 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 1.56e-03 | 16 | 69 | 2 | SM00146 | |
| Domain | C2 | 1.66e-03 | 137 | 69 | 4 | SM00239 | |
| Domain | Hemopexin_CS | 1.76e-03 | 17 | 69 | 2 | IPR018486 | |
| Domain | C2 | 1.89e-03 | 142 | 69 | 4 | PS50004 | |
| Domain | PI3/4_kinase_cat_dom | 1.98e-03 | 18 | 69 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 1.98e-03 | 18 | 69 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 1.98e-03 | 18 | 69 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 1.98e-03 | 18 | 69 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 1.98e-03 | 18 | 69 | 2 | PS00916 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 1.98e-03 | 18 | 69 | 2 | IPR008930 | |
| Domain | BBOX | 2.12e-03 | 69 | 69 | 3 | SM00336 | |
| Domain | Butyrophylin | 2.21e-03 | 70 | 69 | 3 | IPR003879 | |
| Domain | - | 2.30e-03 | 71 | 69 | 3 | 4.10.45.10 | |
| Domain | zf-B_box | 2.40e-03 | 72 | 69 | 3 | PF00643 | |
| Domain | DAPIN | 2.96e-03 | 22 | 69 | 2 | PS50824 | |
| Domain | PYRIN | 2.96e-03 | 22 | 69 | 2 | PF02758 | |
| Domain | DAPIN | 2.96e-03 | 22 | 69 | 2 | IPR004020 | |
| Domain | PYRIN | 2.96e-03 | 22 | 69 | 2 | SM01289 | |
| Domain | ZF_BBOX | 3.24e-03 | 80 | 69 | 3 | PS50119 | |
| Domain | Hemopexin-like_dom | 3.24e-03 | 23 | 69 | 2 | IPR000585 | |
| Domain | Hemopexin-like_repeat | 3.24e-03 | 23 | 69 | 2 | IPR018487 | |
| Domain | Hemopexin | 3.24e-03 | 23 | 69 | 2 | PF00045 | |
| Domain | HEMOPEXIN | 3.24e-03 | 23 | 69 | 2 | PS00024 | |
| Domain | - | 3.24e-03 | 23 | 69 | 2 | 2.110.10.10 | |
| Domain | HEMOPEXIN_2 | 3.24e-03 | 23 | 69 | 2 | PS51642 | |
| Domain | HX | 3.24e-03 | 23 | 69 | 2 | SM00120 | |
| Domain | Znf_B-box | 3.35e-03 | 81 | 69 | 3 | IPR000315 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K | 1.49e-05 | 12 | 59 | 3 | M27905 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K | 1.49e-05 | 12 | 59 | 3 | MM15623 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 4.54e-05 | 17 | 59 | 3 | MM15584 | |
| Pathway | REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING | 1.01e-04 | 22 | 59 | 3 | MM15632 | |
| Pathway | WP_FOCAL_ADHESION | 1.26e-04 | 187 | 59 | 6 | MM15913 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 1.50e-04 | 25 | 59 | 3 | M27865 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 1.64e-04 | 66 | 59 | 4 | MM15925 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_LMP2A_TO_PI3K_SIGNALING_PATHWAY | 1.71e-04 | 5 | 59 | 2 | M48997 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_PI3K_SIGNALING_PATHWAY | 1.71e-04 | 5 | 59 | 2 | M49020 | |
| Pathway | WP_FOCAL_ADHESION | 1.77e-04 | 199 | 59 | 6 | M39402 | |
| Pathway | REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING | 1.90e-04 | 27 | 59 | 3 | M921 | |
| Pathway | WP_IL17_SIGNALING | 3.17e-04 | 32 | 59 | 3 | M39560 | |
| Pathway | WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION | 3.47e-04 | 33 | 59 | 3 | M39745 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 3.57e-04 | 7 | 59 | 2 | MM14685 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY | 3.57e-04 | 7 | 59 | 2 | M47790 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 4.14e-04 | 35 | 59 | 3 | MM15144 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY | 4.74e-04 | 8 | 59 | 2 | M47399 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 4.74e-04 | 8 | 59 | 2 | M47394 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 4.74e-04 | 8 | 59 | 2 | M47395 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY | 4.74e-04 | 8 | 59 | 2 | M47404 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 4.74e-04 | 8 | 59 | 2 | M47405 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 4.74e-04 | 8 | 59 | 2 | M47872 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY | 4.74e-04 | 8 | 59 | 2 | M47803 | |
| Pathway | KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 4.74e-04 | 8 | 59 | 2 | M47482 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 4.74e-04 | 8 | 59 | 2 | M47498 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 4.74e-04 | 8 | 59 | 2 | M27031 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY | 4.74e-04 | 8 | 59 | 2 | M47715 | |
| Pathway | PID_ERBB4_PATHWAY | 5.29e-04 | 38 | 59 | 3 | M13 | |
| Pathway | WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY | 5.72e-04 | 39 | 59 | 3 | M39905 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 6.08e-04 | 9 | 59 | 2 | M47397 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY | 6.08e-04 | 9 | 59 | 2 | M47392 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY | 6.08e-04 | 9 | 59 | 2 | M47391 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY | 6.08e-04 | 9 | 59 | 2 | M47402 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY | 6.08e-04 | 9 | 59 | 2 | M47802 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY | 6.08e-04 | 9 | 59 | 2 | M47490 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY | 6.08e-04 | 9 | 59 | 2 | M47481 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 6.63e-04 | 41 | 59 | 3 | MM15162 | |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 6.90e-04 | 96 | 59 | 4 | M16121 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 7.46e-04 | 98 | 59 | 4 | M965 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 7.58e-04 | 10 | 59 | 2 | M47400 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY | 7.58e-04 | 10 | 59 | 2 | M47401 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY | 7.58e-04 | 10 | 59 | 2 | M47615 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 8.16e-04 | 44 | 59 | 3 | M1012 | |
| Pathway | PID_ERBB2_ERBB3_PATHWAY | 8.16e-04 | 44 | 59 | 3 | M175 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY | 9.24e-04 | 11 | 59 | 2 | M47797 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY | 9.24e-04 | 11 | 59 | 2 | M47403 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 9.24e-04 | 11 | 59 | 2 | M47406 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 9.24e-04 | 11 | 59 | 2 | M47874 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 9.24e-04 | 11 | 59 | 2 | MM1430 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY | 9.24e-04 | 11 | 59 | 2 | M47484 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY | 9.24e-04 | 11 | 59 | 2 | M47499 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY | 9.24e-04 | 11 | 59 | 2 | M47756 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339 | 9.24e-04 | 11 | 59 | 2 | M47791 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY | 9.24e-04 | 11 | 59 | 2 | M47501 | |
| Pathway | WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY | 9.30e-04 | 46 | 59 | 3 | M48317 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 1.05e-03 | 48 | 59 | 3 | M914 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.11e-03 | 12 | 59 | 2 | M47393 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350 | 1.11e-03 | 12 | 59 | 2 | M47798 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 1.11e-03 | 12 | 59 | 2 | M47558 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 1.11e-03 | 12 | 59 | 2 | M47559 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 1.11e-03 | 12 | 59 | 2 | MM1368 | |
| Pathway | WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION | 1.11e-03 | 12 | 59 | 2 | M45559 | |
| Pathway | WP_PHOSPHOINOSITIDES_METABOLISM | 1.12e-03 | 49 | 59 | 3 | M40046 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY | 1.30e-03 | 13 | 59 | 2 | M47398 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY | 1.30e-03 | 13 | 59 | 2 | M47603 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 1.30e-03 | 13 | 59 | 2 | M17842 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 1.30e-03 | 13 | 59 | 2 | MM14747 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 1.30e-03 | 13 | 59 | 2 | M4732 | |
| Pathway | KEGG_INOSITOL_PHOSPHATE_METABOLISM | 1.48e-03 | 54 | 59 | 3 | M3896 | |
| Pathway | WP_IL4_SIGNALING | 1.48e-03 | 54 | 59 | 3 | M39720 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 1.52e-03 | 14 | 59 | 2 | M47390 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BILE_ACID_BIOSYNTHESIS | 1.52e-03 | 14 | 59 | 2 | M47631 | |
| Pathway | PID_IL5_PATHWAY | 1.52e-03 | 14 | 59 | 2 | M135 | |
| Pathway | WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE | 1.52e-03 | 14 | 59 | 2 | M39840 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY | 1.52e-03 | 14 | 59 | 2 | M47467 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY | 1.52e-03 | 14 | 59 | 2 | M47536 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 1.60e-03 | 302 | 59 | 6 | M39719 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 1.75e-03 | 15 | 59 | 2 | M47389 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 1.75e-03 | 15 | 59 | 2 | M47663 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 1.75e-03 | 15 | 59 | 2 | M47475 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 1.75e-03 | 15 | 59 | 2 | M7146 | |
| Pathway | WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS | 1.75e-03 | 15 | 59 | 2 | M39498 | |
| Pathway | WP_SIDS_SUSCEPTIBILITY_PATHWAYS | 1.92e-03 | 59 | 59 | 3 | MM15838 | |
| Pathway | KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS | 1.99e-03 | 16 | 59 | 2 | M3214 | |
| Pathway | WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME | 2.12e-03 | 130 | 59 | 4 | M39787 | |
| Pathway | KEGG_COLORECTAL_CANCER | 2.21e-03 | 62 | 59 | 3 | M14631 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 2.25e-03 | 17 | 59 | 2 | MM15944 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 2.25e-03 | 17 | 59 | 2 | MM1369 | |
| Pathway | SA_PTEN_PATHWAY | 2.25e-03 | 17 | 59 | 2 | M12771 | |
| Pathway | SA_TRKA_RECEPTOR | 2.25e-03 | 17 | 59 | 2 | M18895 | |
| Pathway | WP_TRANSCRIPTIONAL_ACTIVATION_BY_NFE2L2_IN_RESPONSE_TO_PHYTOCHEMICALS | 2.25e-03 | 17 | 59 | 2 | MM15891 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 2.35e-03 | 326 | 59 | 6 | MM15917 | |
| Pathway | WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING | 2.76e-03 | 67 | 59 | 3 | M39630 | |
| Pathway | WP_PI3KAKT_SIGNALING | 2.85e-03 | 339 | 59 | 6 | M39736 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 3.00e-03 | 69 | 59 | 3 | M16894 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 3.12e-03 | 20 | 59 | 2 | M39002 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 3.12e-03 | 20 | 59 | 2 | M917 | |
| Pathway | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | 3.44e-03 | 21 | 59 | 2 | MM15633 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 3.65e-03 | 151 | 59 | 4 | M39801 | |
| Pathway | WP_COMPLEMENT_ACTIVATION | 3.77e-03 | 22 | 59 | 2 | M39502 | |
| Pubmed | 2.72e-07 | 7 | 70 | 3 | 12055255 | ||
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 3.05e-07 | 219 | 70 | 7 | 31353912 | |
| Pubmed | Divergent immunoglobulin g subclass activity through selective Fc receptor binding. | 4.34e-07 | 8 | 70 | 3 | 16322460 | |
| Pubmed | Impaired antibody response causes persistence of prototypic T cell-contained virus. | 4.34e-07 | 8 | 70 | 3 | 19355789 | |
| Pubmed | 6.50e-07 | 9 | 70 | 3 | 1373139 | ||
| Pubmed | TAF6L RNASEH2A ZC3H15 POLR2A DLGAP5 HPX CPVL BAG6 PHIP PALB2 | 6.55e-07 | 645 | 70 | 10 | 25281560 | |
| Pubmed | 1.70e-06 | 12 | 70 | 3 | 31801071 | ||
| Pubmed | Mapping of the L-methylmalonyl-CoA mutase gene to mouse chromosome 17. | 2.20e-06 | 13 | 70 | 3 | 1970332 | |
| Pubmed | Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. | 2.51e-06 | 47 | 70 | 4 | 14760718 | |
| Pubmed | 2.80e-06 | 14 | 70 | 3 | 3745925 | ||
| Pubmed | Vitamin A-enhanced cleft palate susceptibility gene maps between C4 and B144 within the H-2 complex. | 2.80e-06 | 14 | 70 | 3 | 8456115 | |
| Pubmed | Mapping of 12 markers in the proximal region of mouse chromosome 17 using recombinant t haplotypes. | 3.49e-06 | 15 | 70 | 3 | 7749235 | |
| Pubmed | 3.49e-06 | 15 | 70 | 3 | 2885372 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 3.99e-06 | 2 | 70 | 2 | 16565498 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 15998580 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 19062096 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 3.99e-06 | 2 | 70 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 3.99e-06 | 2 | 70 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 3.99e-06 | 2 | 70 | 2 | 17645767 | |
| Pubmed | PI3 kinase alpha and delta promote hematopoietic stem cell activation. | 3.99e-06 | 2 | 70 | 2 | 31120863 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 12207352 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 3.99e-06 | 2 | 70 | 2 | 27758680 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 22387014 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 3.99e-06 | 2 | 70 | 2 | 23749435 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 23918728 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 23341541 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 3.99e-06 | 2 | 70 | 2 | 3037333 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 11726230 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 21525791 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 3.99e-06 | 2 | 70 | 2 | 6950384 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 3.99e-06 | 2 | 70 | 2 | 8428773 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 3.99e-06 | 2 | 70 | 2 | 21345967 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 21188463 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 2572548 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 2302180 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 3.99e-06 | 2 | 70 | 2 | 18091514 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 29080553 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 3.99e-06 | 2 | 70 | 2 | 25339671 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17728371 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 26123310 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 6149580 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 6149581 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 12115608 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 3542363 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 2387317 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 16908004 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 7365238 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 7391573 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17971360 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 3.99e-06 | 2 | 70 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 3.99e-06 | 2 | 70 | 2 | 17971229 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 6881182 | ||
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 3.99e-06 | 2 | 70 | 2 | 17921792 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 3.99e-06 | 2 | 70 | 2 | 6978711 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 35898513 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 28873507 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 276882 | ||
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 3.99e-06 | 2 | 70 | 2 | 6832377 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 3794341 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 22785613 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 32691186 | ||
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 3.99e-06 | 2 | 70 | 2 | 8390682 | |
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 3.99e-06 | 2 | 70 | 2 | 3902619 | |
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 3.99e-06 | 2 | 70 | 2 | 7373044 | |
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 3.99e-06 | 2 | 70 | 2 | 3696167 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 3.99e-06 | 2 | 70 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 3.99e-06 | 2 | 70 | 2 | 16098595 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 3.99e-06 | 2 | 70 | 2 | 15787745 | |
| Pubmed | Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis. | 3.99e-06 | 2 | 70 | 2 | 24043760 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 30026462 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 6559257 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 3.99e-06 | 2 | 70 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 3.99e-06 | 2 | 70 | 2 | 20506482 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 12480675 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 26800705 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 26883061 | ||
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 3.99e-06 | 2 | 70 | 2 | 15390104 | |
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 3.99e-06 | 2 | 70 | 2 | 1699796 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 3.99e-06 | 2 | 70 | 2 | 2997024 | |
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 3.99e-06 | 2 | 70 | 2 | 3624865 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 21857912 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 6208559 | ||
| Pubmed | The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement. | 3.99e-06 | 2 | 70 | 2 | 4514997 | |
| Pubmed | The inheritance of susceptibility to the Gross leukemia virus in mice. | 3.99e-06 | 2 | 70 | 2 | 5919331 | |
| Pubmed | An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. | 3.99e-06 | 2 | 70 | 2 | 3167981 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 7545960 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 30041577 | ||
| Pubmed | Complete cDNA sequence of the fourth component of murine complement. | 3.99e-06 | 2 | 70 | 2 | 3862104 | |
| Pubmed | The BS variant of C4 protects against age-related loss of white matter microstructural integrity. | 3.99e-06 | 2 | 70 | 2 | 34358307 | |
| Pubmed | Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d. | 3.99e-06 | 2 | 70 | 2 | 18360261 | |
| Pubmed | Schizophrenia risk from complex variation of complement component 4. | 3.99e-06 | 2 | 70 | 2 | 26814963 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 8132550 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 2395880 | ||
| Interaction | NCR3 interactions | 3.47e-06 | 120 | 69 | 6 | int:NCR3 | |
| Interaction | IL5RA interactions | 4.20e-06 | 124 | 69 | 6 | int:IL5RA | |
| Interaction | CFC1 interactions | 4.60e-06 | 126 | 69 | 6 | int:CFC1 | |
| Cytoband | 11p15 | 4.01e-05 | 43 | 70 | 3 | 11p15 | |
| Cytoband | 6p21.3 | 5.94e-04 | 250 | 70 | 4 | 6p21.3 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 2.33e-04 | 8 | 53 | 2 | 831 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 3.00e-04 | 9 | 53 | 2 | 1234 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 1.40e-03 | 19 | 53 | 2 | 832 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 2.42e-03 | 25 | 53 | 2 | 994 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 2.72e-03 | 95 | 53 | 3 | 59 | |
| GeneFamily | SH2 domain containing | 3.24e-03 | 101 | 53 | 3 | 741 | |
| GeneFamily | Complement system|Sushi domain containing | 4.98e-03 | 36 | 53 | 2 | 492 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 5.26e-03 | 37 | 53 | 2 | 454 | |
| GeneFamily | Phospholipases | 6.73e-03 | 42 | 53 | 2 | 467 | |
| Coexpression | GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN | 3.96e-06 | 159 | 69 | 6 | M6086 | |
| Coexpression | GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_UP | 1.43e-05 | 199 | 69 | 6 | M9306 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.43e-06 | 146 | 70 | 5 | 26493014daa432db721613ef480d133f3da9eb58 | |
| ToppCell | Posterior_cortex-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Htra1)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.04e-05 | 86 | 70 | 4 | c6c0e8e562ffc705e0cd3f503a9e43ca2669e9b0 | |
| ToppCell | Posterior_cortex-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Htra1)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.04e-05 | 86 | 70 | 4 | c1181a7e9f4cbde5a3bee7b54d6448dfce58b238 | |
| ToppCell | Posterior_cortex-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Htra1)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.04e-05 | 86 | 70 | 4 | 4263673abf183f2e04f1a2bf37e365a25b8cb0b4 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-05 | 191 | 70 | 5 | b270c3dd5952f56b9bdceabe13e298fe6757563b | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-05 | 191 | 70 | 5 | 27f23c2254b610abac1a88d0fecff305addde9da | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-05 | 193 | 70 | 5 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-05 | 193 | 70 | 5 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-05 | 193 | 70 | 5 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | Adult-Immune-monocyte|Adult / Lineage, Cell type, age group and donor | 1.43e-05 | 196 | 70 | 5 | 3ef193c5180de3137daf886492e74fc574bc9767 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-05 | 198 | 70 | 5 | 623f9d64c9e800d2d7f623392bf2f22b563f0249 | |
| ToppCell | mLN-(5)_Dendritic_cell-(54)_pDC|mLN / shred on region, Cell_type, and subtype | 1.54e-05 | 199 | 70 | 5 | 1e738219784a446ee8b0ddeb408e0050e1929e60 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.54e-05 | 199 | 70 | 5 | ac866ae110967c5867ff4601939b79861d43df54 | |
| ToppCell | mLN-Dendritic_cell-pDC|mLN / Region, Cell class and subclass | 1.54e-05 | 199 | 70 | 5 | 54f1abb57af7bf8a8b82a38b933f257df3b5d8df | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.58e-05 | 200 | 70 | 5 | fd72fe6565e2f4885481991492d58c323ab1ad40 | |
| ToppCell | (54)_pDC|World / shred on Cell_type and subtype | 1.70e-05 | 203 | 70 | 5 | b8ba3e51770ff7b45cd02472f3e63aa4d5816f6f | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-8|TCGA-Lung / Sample_Type by Project: Shred V9 | 6.45e-05 | 137 | 70 | 4 | 05ca83c30e3dbe74c81278b3636d57da2c20b458 | |
| ToppCell | COVID-19_Mild-Neu_2|World / 5 Neutrophil clusters in COVID-19 patients | 7.02e-05 | 140 | 70 | 4 | b1429028c52f84127b894b93b55961badcd5246f | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.42e-05 | 142 | 70 | 4 | be63c48794a227ea55978524c0f5935342fc455e | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 154 | 70 | 4 | 75eac6970259a6916fcfa6d3400509cfa2d98d9d | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 1.04e-04 | 155 | 70 | 4 | 83430a64c2cb5ad29caa3dacba76c28dd204ac40 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 156 | 70 | 4 | 3f0b9e35d4da85c90759b930052e5b9c3cde9b15 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 156 | 70 | 4 | 69e6e8810d1738a66c9821910f41498931cf30cc | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 157 | 70 | 4 | 2b60de520edf167f5ca790b478557a778435b3d9 | |
| ToppCell | facs-Liver|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 158 | 70 | 4 | ea7db6bd9742153ceb6e444892a6d1df9c7fcc96 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-04 | 160 | 70 | 4 | 5cc1b75e3c20d83112b3aa2f3c749a6c73910a2d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-04 | 162 | 70 | 4 | 9b1c07f0af657095379380c39d763cab0ad73e74 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2-Exc_L3-5_FEZF2_DCN|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.32e-04 | 165 | 70 | 4 | aad0ab96d9d4387edfcef2b114346a030eb4b021 | |
| ToppCell | Adult-Immune-natural_killer_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.39e-04 | 167 | 70 | 4 | ff1ce3b1a2d91d2ad979f25899db4f4eeb865892 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-04 | 168 | 70 | 4 | 0ffad93ba2fb5d4cfda2c13011059555475dcfc8 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-04 | 168 | 70 | 4 | ab1fb9b2cc7c5853b7fbd373e1784a9a31f96d38 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 169 | 70 | 4 | 58136b8a0bf2dab45c91a053ef7225ea49ccb871 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.45e-04 | 169 | 70 | 4 | e7470a5b060881b2a8ce2ab04b0788396aa13889 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 169 | 70 | 4 | 04c6ed38e1d1befba5ef5f37a3c1e045a0b163d6 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 174 | 70 | 4 | c58328c2f262506a4518f49f148e29874faf9171 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.66e-04 | 175 | 70 | 4 | bde785ff0c854646d7ab8571359e9d69a7bf013f | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.70e-04 | 176 | 70 | 4 | d6e660df92a3d7dd5732171ee623763faf108476 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.73e-04 | 177 | 70 | 4 | 6f6cf93893daac6ae228df36219ee3acf8de8f97 | |
| ToppCell | Dendritic_Cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.77e-04 | 178 | 70 | 4 | 3a28103cf282cc3637d1875a3b4cd7ddf3207687 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.81e-04 | 179 | 70 | 4 | 124da6f882968dc0d05f3edd8f3b4d61617cc214 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 179 | 70 | 4 | a09647750eba9d93c5efc1db3b555fefb5eec7b5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.81e-04 | 179 | 70 | 4 | edc5ef693dc4e7ea70717b77fb908fc784dce3a2 | |
| ToppCell | facs-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 182 | 70 | 4 | 4c5d14e33ebdf117b5aa9e2f57aaa89aa51f72bf | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.93e-04 | 182 | 70 | 4 | b86690c109cdc16844a6cd2216c1bf2bf28efd45 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.97e-04 | 183 | 70 | 4 | a644258ba90acc62d571623e429d72ffc4b69203 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.97e-04 | 183 | 70 | 4 | fc9a7ba148c22d0c8a46f6bc56c772929ac496f7 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 183 | 70 | 4 | ebe369dc80c4fbf8f4dbe947147f8c47507ffb60 | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-04 | 184 | 70 | 4 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | (4)_Endothelial_cells-(40)_EC-arterial|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.01e-04 | 184 | 70 | 4 | 7e1a2971321ddcfa00d78d3e3ba7960e532f9392 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.01e-04 | 184 | 70 | 4 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.01e-04 | 184 | 70 | 4 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | Endothelial-E|World / shred on cell class and cell subclass (v4) | 2.01e-04 | 184 | 70 | 4 | b4c561924c508536fd2112e91e32176b95fdf63a | |
| ToppCell | IIH-pDC-|IIH / Condition, Cell_class and T cell subcluster | 2.14e-04 | 187 | 70 | 4 | ad87b146ea8dd9f695e722f8f0e8e1057c7f3167 | |
| ToppCell | IIH-pDC|IIH / Condition, Cell_class and T cell subcluster | 2.14e-04 | 187 | 70 | 4 | 5e59e9153a18bcfb5c8dc94599080216661de7ce | |
| ToppCell | COVID-NK-|COVID / Condition, Cell_class and T cell subcluster | 2.18e-04 | 188 | 70 | 4 | fabdd68a9734d35e75e1f4a4bfd5c531cfc099f1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.18e-04 | 188 | 70 | 4 | 9abd78970bbe4ed03b59a83da63bbd334712f605 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.18e-04 | 188 | 70 | 4 | f7dc29dfec68236883469e848be5db34f5526d6b | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-04 | 188 | 70 | 4 | 405efea75233ecf70f7d19b630230798d817b7f2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.18e-04 | 188 | 70 | 4 | 5ae8ccdd328cf117da1d01ced2c3b7f763a5f1f1 | |
| ToppCell | COVID-NK|COVID / Condition, Cell_class and T cell subcluster | 2.18e-04 | 188 | 70 | 4 | 0beaa671611110a11e46156f54f5202cc24967a4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.23e-04 | 189 | 70 | 4 | cfa45fa6b13fcd3f54c29c823885f5b938812474 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.23e-04 | 189 | 70 | 4 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 190 | 70 | 4 | 9d5242759546be0089981ef1877e4ed5f81face5 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.27e-04 | 190 | 70 | 4 | e1b721bb74561fe51c53328a0394c9954e489049 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.27e-04 | 190 | 70 | 4 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | 21-Trachea-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 2.27e-04 | 190 | 70 | 4 | bce09634acbc2cfd53666328e8aed8bf8835f845 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 190 | 70 | 4 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | (1)_Control_(PBS)-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 2.27e-04 | 190 | 70 | 4 | ec0ab31266583a0966ac7615d5c0fabb7b7e66e8 | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.27e-04 | 190 | 70 | 4 | d072bb285bd34d518b958e7c9ad44739c60b359c | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 190 | 70 | 4 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 190 | 70 | 4 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.27e-04 | 190 | 70 | 4 | 9b0ad888eb20acc011904d8593bc32bdef18d050 | |
| ToppCell | 21-Trachea-Endothelial-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 2.27e-04 | 190 | 70 | 4 | 08437396a98ca9526f69c3a74bbf2929f3c68b8e | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.32e-04 | 191 | 70 | 4 | 0e8a73f01e3ec95d242c09231bcf3790324d0a67 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.32e-04 | 191 | 70 | 4 | fcdf3a747038e346a467eae8b7c293592658b53f | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.32e-04 | 191 | 70 | 4 | 54bbccc554f43ba2ebdf9ea191b94c8f16081b53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-04 | 191 | 70 | 4 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.36e-04 | 192 | 70 | 4 | eafead22bba48ac5ee568faa8946c444445c1034 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 192 | 70 | 4 | f4cd65e6c5b17bcabf45fe5b687246c72e7975f7 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-04 | 192 | 70 | 4 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.36e-04 | 192 | 70 | 4 | 5a3c66fc3ae22bd9ac90ca137dee0bcabcd20ab8 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-04 | 192 | 70 | 4 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 192 | 70 | 4 | bcd8876235be503186f119653b39476488c0fa15 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 192 | 70 | 4 | 5890076929598e88fe9d59a4e4e858b446746ce9 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.36e-04 | 192 | 70 | 4 | c157981b9a179925edcaabc0cb3b8805f0929004 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.36e-04 | 192 | 70 | 4 | 1f348e23843405abb1f1dc7d739fc5647333de16 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.36e-04 | 192 | 70 | 4 | cd4c9b9ab17a779c154264f7459020f51e528ba5 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.41e-04 | 193 | 70 | 4 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.41e-04 | 193 | 70 | 4 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-04 | 193 | 70 | 4 | 4a8c97ff2dffc5c06351d1cb107e21e58250aa55 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-04 | 193 | 70 | 4 | d5f6d6e2c36d4e80af4d39cdfc0b18df295a587b | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.41e-04 | 193 | 70 | 4 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | VE-pDC-|VE / Condition, Cell_class and T cell subcluster | 2.41e-04 | 193 | 70 | 4 | 583724de588fcde3aeda056138c522dc0225a387 | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.41e-04 | 193 | 70 | 4 | 5f9a7cd5f8eb9ac294cdb50518fedf872f3f78f5 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.41e-04 | 193 | 70 | 4 | 58c590dd6f21bc7ae58ae1729dd574c0f1069592 | |
| ToppCell | VE-pDC|VE / Condition, Cell_class and T cell subcluster | 2.41e-04 | 193 | 70 | 4 | bb759dc9ef0ec41d655002f59021d62d62d44289 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-04 | 194 | 70 | 4 | e2db75f4de114631b8bda4e188f84446545538b7 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-04 | 194 | 70 | 4 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Adult-Immune-monocyte-D122|Adult / Lineage, Cell type, age group and donor | 2.56e-04 | 196 | 70 | 4 | 16b0acb6157534938ca83d4e909471e33a7d3c52 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.56e-04 | 196 | 70 | 4 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 3.15e-05 | 27 | 67 | 3 | C1112155 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 3.92e-05 | 29 | 67 | 3 | C1333990 | |
| Disease | Breast Cancer, Familial | 4.35e-05 | 30 | 67 | 3 | C0346153 | |
| Disease | endometrial cancer (is_implicated_in) | 7.57e-05 | 36 | 67 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | essential thrombocythemia (is_implicated_in) | 7.57e-05 | 6 | 67 | 2 | DOID:2224 (is_implicated_in) | |
| Disease | Autoimmune Diseases | 1.21e-04 | 42 | 67 | 3 | C0004364 | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 1.29e-04 | 43 | 67 | 3 | DOID:9074 (implicated_via_orthology) | |
| Disease | monocyte percentage of leukocytes | 2.46e-04 | 731 | 67 | 8 | EFO_0007989 | |
| Disease | leukemia | 2.70e-04 | 55 | 67 | 3 | C0023418 | |
| Disease | Diffuse Large B-Cell Lymphoma | 2.70e-04 | 55 | 67 | 3 | C0079744 | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 3.85e-04 | 62 | 67 | 3 | DOID:9074 (is_implicated_in) | |
| Disease | mean platelet volume | 4.81e-04 | 1020 | 67 | 9 | EFO_0004584 | |
| Disease | Prostatic Neoplasms | 4.91e-04 | 616 | 67 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 4.91e-04 | 616 | 67 | 7 | C0376358 | |
| Disease | Lupus Erythematosus, Systemic | 5.73e-04 | 71 | 67 | 3 | C0024141 | |
| Disease | reticulocyte count | 5.73e-04 | 1045 | 67 | 9 | EFO_0007986 | |
| Disease | Liver diseases | 5.97e-04 | 72 | 67 | 3 | C0023895 | |
| Disease | Liver Dysfunction | 5.97e-04 | 72 | 67 | 3 | C0086565 | |
| Disease | Necrotizing Enterocolitis | 6.76e-04 | 17 | 67 | 2 | C0520459 | |
| Disease | mean corpuscular hemoglobin concentration | FCGR2B PIK3CA POLR2A DLGAP4 LINC00299 PFAS TRIM34 MEFV NLRP6 | 8.52e-04 | 1105 | 67 | 9 | EFO_0004528 |
| Disease | Adenocarcinoma of prostate | 9.40e-04 | 20 | 67 | 2 | C0007112 | |
| Disease | colorectal carcinoma (is_implicated_in) | 1.14e-03 | 22 | 67 | 2 | DOID:0080199 (is_implicated_in) | |
| Disease | progranulin measurement | 1.14e-03 | 22 | 67 | 2 | EFO_0004625 | |
| Disease | Neoplasm of the genitourinary tract | 1.36e-03 | 24 | 67 | 2 | cv:C0042065 | |
| Disease | Behcet Syndrome | 1.36e-03 | 24 | 67 | 2 | C0004943 | |
| Disease | breast cancer (implicated_via_orthology) | 1.47e-03 | 25 | 67 | 2 | DOID:1612 (implicated_via_orthology) | |
| Disease | colon adenocarcinoma (is_marker_for) | 1.47e-03 | 25 | 67 | 2 | DOID:234 (is_marker_for) | |
| Disease | eosinophil percentage of leukocytes | 1.50e-03 | 746 | 67 | 7 | EFO_0007991 | |
| Disease | S-6-hydroxywarfarin measurement | 1.51e-03 | 368 | 67 | 5 | EFO_0803326 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 1.59e-03 | 26 | 67 | 2 | C0009405 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 1.59e-03 | 26 | 67 | 2 | DOID:234 (is_implicated_in) | |
| Disease | Malignant tumor of breast | 1.72e-03 | 27 | 67 | 2 | cv:C0006142 | |
| Disease | Breast neoplasm | 1.72e-03 | 27 | 67 | 2 | cv:C1458155 | |
| Disease | Familial cancer of breast | 1.72e-03 | 27 | 67 | 2 | cv:C0346153 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 1.93e-03 | 108 | 67 | 3 | DOID:684 (biomarker_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 1.98e-03 | 29 | 67 | 2 | C0496920 | |
| Disease | Ovarian Carcinoma | 2.12e-03 | 30 | 67 | 2 | C0029925 | |
| Disease | basophil count, eosinophil count | 2.22e-03 | 241 | 67 | 4 | EFO_0004842, EFO_0005090 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GRYCMAPAPQAPERD | 151 | Q5DID0 | |
| HFYPRLRCGMLIGPD | 86 | Q6ZSB3 | |
| LPRGCGEQTMIYLAP | 1006 | P0C0L5 | |
| SRMETLPYLQCRGGP | 181 | P46379 | |
| PFGLMRRELACEGYP | 31 | O94910 | |
| PGPFCAMVLADFGAR | 16 | Q9UHK6 | |
| SPLLPMDYEEFVRGC | 486 | P54840 | |
| RISALPGYPECREMG | 251 | P31994 | |
| EYMRSLPGPKRGVAC | 176 | O43143 | |
| FYNLTICARDRGMPP | 1816 | Q9H251 | |
| EGPIPCRRMRSGSYI | 356 | Q9Y2H0 | |
| GRLPRPDGCPDEIYM | 1086 | O60674 | |
| VMYGCDVGPDGPFLR | 121 | P01893 | |
| PVPMLSARLRYCAGN | 161 | Q8NGH8 | |
| LFGAAPRYPLMDRFE | 516 | Q96F46 | |
| LMALLYPDCGGGRLD | 201 | Q6N063 | |
| PGRYICSEMDLGGLP | 161 | Q8NCI6 | |
| AYPADELMPLTCRGR | 71 | Q9BZQ6 | |
| MPGPCDGLFRSLYRS | 16 | Q9H3G5 | |
| CRPFEVYLPSGKMRP | 226 | O15553 | |
| DCMYAPLLGVPPAVR | 266 | P10275 | |
| LRFPGYRGCIEMDTL | 2891 | O15230 | |
| YSRGGDGPMCRPVIL | 1066 | P52701 | |
| PMRDCLYLVDGGFAI | 671 | Q68DD2 | |
| LLDCNYPDPMVRGFA | 601 | P42336 | |
| YPDPMVRGFAVRCLE | 606 | P42336 | |
| AFLRVDAGYRMPCPL | 396 | Q13882 | |
| MLYCLPPGQAGRFLE | 1106 | Q86YC2 | |
| PDSNPPGGMFCRYDR | 196 | O14786 | |
| ALGAGCRLYDMRLSP | 146 | Q9Y426 | |
| GIFKVGRYRPDMPCF | 116 | Q15398 | |
| MASLDLPYRCPRCGE | 1 | Q8TF61 | |
| RREAPYGAPRFDMPD | 1461 | Q8N2S1 | |
| LGMVPPCRLYRARAG | 646 | Q6UWL6 | |
| DMRLPPYGLCERGDP | 546 | Q9P1Z2 | |
| PRFARLADMYGHPCG | 771 | P55291 | |
| PECRMIGLRLYDGLF | 126 | Q16531 | |
| FAFFMPCGELLERPG | 231 | P59044 | |
| LPRGCGEQTMIYLAP | 1006 | P0C0L4 | |
| AGYLCLPGMLRQRRP | 16 | Q9UNU6 | |
| GPNRVDYIFCDIPAM | 191 | Q8NH81 | |
| PRDVRDYFMPCPGRG | 221 | P02790 | |
| CGYGSQEALPMRPAR | 81 | Q9Y6J9 | |
| MAVPPCRVGVFLDYE | 426 | Q9BYJ4 | |
| EYYVGPPLQRGDMIC | 1346 | O60522 | |
| CGYLLKPDFMRRPDR | 671 | Q15147 | |
| VRAGCAPLMEAYGFP | 131 | Q5T4F7 | |
| AGRGPVLGPMVYAIC | 36 | O75792 | |
| RGPMPARIGYYEIDR | 56 | Q9Y2K2 | |
| DRINVYGMVPPDFCR | 246 | Q9BVH7 | |
| PDPGYLMGVRELCTR | 241 | P04181 | |
| GAERMPRAPGGFECF | 141 | Q3KNW1 | |
| GGGAPLRVELPTCMY | 11 | Q13155 | |
| GLYGAMVRHCIPLPD | 236 | Q9NZR4 | |
| VGDPFGPRCYKGDIM | 311 | Q8NCJ5 | |
| RRGRVPEPCIFYEEM | 321 | Q9NX65 | |
| PGLYMDERGDCVPKA | 691 | P04275 | |
| YPRSILKDFMGCDGP | 521 | P51512 | |
| PRRCPFVPQMGDEVY | 951 | Q8WWQ0 | |
| EERGLRERMGPSYCL | 1031 | O15067 | |
| EECFVLGMEPRYARP | 231 | P24928 | |
| YRGNCRPIRFEPPML | 101 | Q92545 | |
| RYDFAIMIPPGGTEC | 41 | Q8WW62 | |
| LDLRMTPYGCLPTGD | 806 | O00329 | |
| RAPVGDMPYRCDVCG | 341 | Q9UJW7 | |
| RLRYPVGLMGSCLPA | 241 | P42681 | |
| CLYILDRRGMPYGGR | 301 | P22735 | |
| GGDICMYRHALPPGF | 201 | Q8WU90 | |
| GGVMEQTRPCLPRSY | 71 | Q6ZMP0 | |
| MAVPPCRIGVFLDYE | 436 | Q8IYM9 | |
| YMLHPRDGGCPAKRL | 46 | Q9H898 |